The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat ; volume:18 ; number:1 ; day:25 ; month:3 ; year:2019 ; pages:1-17 ; date:12.2019
Cardiovascular diabetology ; 18, Heft 1 (25.3.2019), 1-17, 12.2019
- Creator
-
Habibi, Javad
Aroor, Annayya R.
Das, Nitin A.
Manrique-Acevedo, Camila M.
Johnson, Megan S.
Hayden, Melvin R.
Nistala, Ravi
Wiedmeyer, Charles
Chandrasekar, Bysani
DeMarco, Vincent G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-019-0847-8
- URN
-
urn:nbn:de:101:1-2019041621090081141074
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Habibi, Javad
- Aroor, Annayya R.
- Das, Nitin A.
- Manrique-Acevedo, Camila M.
- Johnson, Megan S.
- Hayden, Melvin R.
- Nistala, Ravi
- Wiedmeyer, Charles
- Chandrasekar, Bysani
- DeMarco, Vincent G.
- SpringerLink (Online service)
Other Objects (12)
Hospitalization Rates in Patients with Heart Failure and Reduced Ejection Fraction Initiating Sacubitril/Valsartan or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: A Retrospective Cohort Study
Glomerular podocyte dysfunction in inherited renal tubular disease
Neprilysin Inhibitor–Angiotensin II Receptor Blocker Combination Therapy (Sacubitril/valsartan) Suppresses Atherosclerotic Plaque Formation and Inhibits Inflammation in Apolipoprotein E- Deficient Mice
Renin-angiotensin system blockers and COVID-19
Angiotensin II-Antagonist Valsartan : Ergebnisse einer doppelblinden, placebo-kontrollierten Multicenter-Studie
Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker in Cerebral Arteriogenesis
Contribution of angiotensin converting enzyme to angiotensin receptor blocker induced angio-oedema
Angiotensin Receptor Blockers and Cognition: a Scoping Review
The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial
Etiopathology of chronic tubular, glomerular and renovascular nephropathies: Clinical implications
Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients
Hospitalization Rates in Patients with Heart Failure and Reduced Ejection Fraction Initiating Sacubitril/Valsartan or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: A Retrospective Cohort Study
Glomerular podocyte dysfunction in inherited renal tubular disease
Neprilysin Inhibitor–Angiotensin II Receptor Blocker Combination Therapy (Sacubitril/valsartan) Suppresses Atherosclerotic Plaque Formation and Inhibits Inflammation in Apolipoprotein E- Deficient Mice
Renin-angiotensin system blockers and COVID-19
Angiotensin II-Antagonist Valsartan : Ergebnisse einer doppelblinden, placebo-kontrollierten Multicenter-Studie
Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker in Cerebral Arteriogenesis
Contribution of angiotensin converting enzyme to angiotensin receptor blocker induced angio-oedema
Angiotensin Receptor Blockers and Cognition: a Scoping Review
The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial
Etiopathology of chronic tubular, glomerular and renovascular nephropathies: Clinical implications
Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients
Hospitalization Rates in Patients with Heart Failure and Reduced Ejection Fraction Initiating Sacubitril/Valsartan or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: A Retrospective Cohort Study
Glomerular podocyte dysfunction in inherited renal tubular disease
Neprilysin Inhibitor–Angiotensin II Receptor Blocker Combination Therapy (Sacubitril/valsartan) Suppresses Atherosclerotic Plaque Formation and Inhibits Inflammation in Apolipoprotein E- Deficient Mice
Renin-angiotensin system blockers and COVID-19
Angiotensin II-Antagonist Valsartan : Ergebnisse einer doppelblinden, placebo-kontrollierten Multicenter-Studie
Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker in Cerebral Arteriogenesis
Contribution of angiotensin converting enzyme to angiotensin receptor blocker induced angio-oedema
Angiotensin Receptor Blockers and Cognition: a Scoping Review
The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial
Etiopathology of chronic tubular, glomerular and renovascular nephropathies: Clinical implications
Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels